|
1 Company |
|
1 Product |
|
1 Product |
|
1 Mechanism of Action |
|
0 Trials |
|
7 News |
|
- Trial completion, Trial primary completion date: Evaluating the Safety and Immunogenicity of a Live Attenuated West Nile Virus Vaccine for West Nile Encephalitis in Adults 50 to 65 Years of Age (clinicaltrials.gov) - Feb 1, 2017
P1, N=28, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed | Trial primary completion date: May 2015 --> Jul 2016
- Enrollment closed: Evaluating the Safety and Immunogenicity of a Live Attenuated West Nile Virus Vaccine for West Nile Encephalitis in Adults 50 to 65 Years of Age (clinicaltrials.gov) - Dec 15, 2015
P1, N=28, Active, not recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed | Trial primary completion date: May 2015 --> Jul 2016 Recruiting --> Active, not recruiting
- Enrollment open: Evaluating the Safety and Immunogenicity of a Live Attenuated West Nile Virus Vaccine for West Nile Encephalitis in Adults 50 to 65 Years of Age (clinicaltrials.gov) - Aug 6, 2014
P1, N=28, Recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Active, not recruiting Active, not recruiting --> Recruiting
- New P1 trial: Evaluating the Safety and Immunogenicity of a Live Attenuated West Nile Virus Vaccine for West Nile Encephalitis in Adults 50 to 65 Years of Age (clinicaltrials.gov) - Jul 12, 2014
P1, N=28, Active, not recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- | Trial completion: Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4-3'delta30) in Healthy Adults (clinicaltrials.gov) - Feb 22, 2014
P1, N=56, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Recruiting Recruiting --> Completed
- | Omr-IgG-am (intravenous normal human immunoglobulin) / J&J
Trial completion: IVIG - West Nile Encephalitis: Safety and Efficacy (clinicaltrials.gov) - Feb 22, 2014
P1/2, N=62, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Completed Active, not recruiting --> Completed
- Enrollment change: Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4delta30) in Healthy Adults (clinicaltrials.gov) - Dec 30, 2012
P1, N=26, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed N=50 --> 26